Search Sciety

Showing page 2 of 1164 pages of search results

• Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

  This article's authors

  1. Hemmi T
  2. Ainai A
  3. Hashiguchi T
  4. Tobiume M
  5. Kanno T
  6. Iwata-Yoshikawa N
  7. Iida S
  8. Sato Y
  9. Miyamoto S
  10. Ueno A
  11. Sano K
  12. Saito S
  13. Shiwa-Sudo N
  14. Nagata N
  15. Tamura K
  16. Suzuki R
  17. Hasegawa H
  18. Suzuki T

• Predicting recognition between T cell receptors and epitopes using contextualized motifs

  This article's authors

  1. Jokinen E
  2. Dumitrescu A
  3. Huuhtanen J
  4. Gligorijević V
  5. Mustjoki S
  6. Bonneau R
  7. Heinonen M
  8. Lähdesmäki H

• RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity

  This article's authors

  1. Angioni R
  2. Bonfanti M
  3. Caporale N
  4. Sánchez-Rodríguez R
  5. Munari F
  6. Savino A
  7. Buratto D
  8. Pagani I
  9. Bertoldi N
  10. Zanon C
  11. Ferrari P
  12. Ricciardelli E
  13. Putaggio C
  14. Ghezzi S
  15. Elli F
  16. Rotta L
  17. Iorio F
  18. Zonta F
  19. Cattelan A
  20. Vicenzi E
  21. Molon B
  22. Villa C
  23. Viola A
  24. Testa G

• Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide

  This article's authors

  1. Chi LA
  2. Asgharpour S
  3. Correa-Basurto J
  4. Bandala CR
  5. Martínez-Archundia M

• Barriers and enablers to diabetic eye screening: a cross sectional survey of young adults with type 1 and type 2 diabetes in the UK

  This article's authors

  1. Prothero L
  2. Cartwright M
  3. Lorencatto F
  4. Burr JM
  5. Anderson J
  6. Gardner P
  7. Presseau J
  8. Ivers N
  9. Grimshaw JM
  10. Lawrenson JG
  11. the EROS Study Investigators

• Variant-specific symptoms of COVID-19 among 1,542,510 people in England

  This article's authors

  1. Whitaker M
  2. Elliott J
  3. Bodinier B
  4. Barclay W
  5. Ward H
  6. Cooke G
  7. Donnelly CA
  8. Chadeau-Hyam M
  9. Elliott P

• COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022

  This article's authors

  1. Marquez C
  2. Kerkhoff AD
  3. Schrom J
  4. Rojas S
  5. Black D
  6. Mitchell A
  7. Wang C
  8. Pilarowski G
  9. Ribeiro S
  10. Jones D
  11. Payan J
  12. Manganelli S
  13. Rojas S
  14. Lemus J
  15. Jain V
  16. Chamie G
  17. Tulier-Laiwa V
  18. Petersen M
  19. DeRisi J
  20. Havlir DV

• A Mesoscale Agent Based Modeling Framework For Flow-mediated Infection Transmission In Indoor Occupied Spaces

  This article's authors

  1. Mukherjee D
  2. Wadhwa G

• Machine Learning for Identifying Data-Driven Subphenotypes of Incident Post-Acute SARS-CoV-2 Infection Conditions with Large Scale Electronic Health Records: Findings from the RECOVER Initiative

  This article's authors

  1. Zhang H
  2. Zang C
  3. Xu Z
  4. Zhang Y
  5. Xu J
  6. Bian J
  7. Morozyuk D
  8. Khullar D
  9. Zhang Y
  10. Nordvig AS
  11. Schenck EJ
  12. Shenkman EA
  13. Rothman RL
  14. Block JP
  15. Lyman K
  16. Weiner MG
  17. Carton TW
  18. Wang F
  19. Kaushal R

• Does directly integrating health information exchange (HIE) data with the electronic health record increase HIE use by clinicians in the emergency department?

  This article's authors

  1. Hosler H
  2. Jang JH
  3. Schaffer JT
  4. Price J
  5. Schleyer TK
  6. Rivera RL

• Omicron and vaccines: An analysis on the decline in COVID-19 mortality

  This article's authors

  1. Larrauri BJ
  2. Malbrán A
  3. Larrauri JA

• Assessment of subtle cognitive impairments in patients with post-COVID syndrome with the tablet-based Oxford Cognitive Screen-Plus (OCS-Plus)

  This article's authors

  1. Kozik V
  2. Reuken P
  3. Utech I
  4. Gramlich J
  5. Stallmach Z
  6. Demeyere N
  7. Stallmach A
  8. Finke K

• National PReCePT Programme: a quasi-experimental before-and-after evaluation of the implementation of a national quality improvement programme to increase the uptake of magnesium sulphate in pre-term deliveries

  This article's authors

  1. Edwards HB
  2. Redaniel MT
  3. Sillero-Rejon C
  4. Margelyte R
  5. Peters TJ
  6. Tilling K
  7. Hollingworth W
  8. McLeod H
  9. Craggs P
  10. Hill EM
  11. Redwood S
  12. Donovan JL
  13. Treloar E
  14. Wetz E
  15. Swinscoe N
  16. Ford GA
  17. Macleod J
  18. Luyt K

• Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform

  This article's authors

  1. Zheng B
  2. Green AC
  3. Tazare J
  4. Curtis HJ
  5. Fisher L
  6. Nab L
  7. Schultze A
  8. Mahalingasivam V
  9. Parker EP
  10. Hulme WJ
  11. Bacon SC
  12. DeVito NJ
  13. Bates C
  14. Evans D
  15. Inglesby P
  16. Drysdale H
  17. Davy S
  18. Cockburn J
  19. Morton CE
  20. Hickman G
  21. Ward T
  22. Smith RM
  23. Parry J
  24. Hester F
  25. Harper S
  26. Mehrkar A
  27. Eggo RM
  28. Walker AJ
  29. Evans SJ
  30. Douglas IJ
  31. MacKenna B
  32. Goldacre B
  33. Tomlinson LA

• Low testing rates limit the ability of genomic surveillance programs to monitor SARS-CoV-2 variants: a mathematical modelling study

  This article's authors

  1. Han AX
  2. Toporowski A
  3. Sacks JA
  4. Perkins M
  5. Briand S
  6. van Kerkhove M
  7. Hannay E
  8. Carmona S
  9. Rodriguez B
  10. Parker E
  11. Nichols BE
  12. Russell CA

• Evaluation of standard and enhanced quality improvement methods to increase the uptake of magnesium sulphate in pre-term deliveries for the prevention of neurodisability (PReCePT Study): a cluster randomized controlled trial

  This article's authors

  1. Edwards HB
  2. Redaniel MT
  3. Sillero-Rejon C
  4. Pithara-McKeown C
  5. Margelyte R
  6. Stone T
  7. Peters T
  8. McLeod H
  9. Hollingworth W
  10. Craggs P
  11. Hill EM
  12. Redwood S
  13. Treloar E
  14. Donovan JL
  15. Opmeer BC
  16. Luyt K

• Safety of the BNT162b2 mRNA COVID-19 Vaccine in Children below 5 Years (CoVacU5) – an Investigator-Initiated Retrospective Cohort Study

  This article's authors

  1. Töpfner N
  2. von Meißner WCG
  3. Strumann C
  4. Drinka D
  5. Stuppe D
  6. Jorczyk M
  7. Moor J
  8. Püschel J
  9. Liss M
  10. Poblotzki Ev
  11. Berner R
  12. Moor MB
  13. Chao C

• Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques

  This article's authors

  1. Le Nouën C
  2. Nelson CE
  3. Liu X
  4. Park H
  5. Matsuoka Y
  6. Luongo C
  7. Santos C
  8. Yang L
  9. Herbert R
  10. Castens A
  11. Moore IN
  12. Wilder-Kofie T
  13. Moore R
  14. Walker A
  15. Zhang P
  16. Lusso P
  17. Johnson RF
  18. Garza NL
  19. Via LE
  20. Munir S
  21. Barber D
  22. Buchholz UJ

• Using a reverse genetics system to generate recombinant SARS-CoV-2 expressing robust levels of reporter genes

  This article's authors

  1. Ye C
  2. Martinez-Sobrido L

• The SARS-CoV-2 spike protein binds and modulates estrogen receptors

  This article's authors

  1. Solis O
  2. Beccari AR
  3. Iaconis D
  4. Talarico C
  5. Ruiz-Bedoya CA
  6. Nwachukwu JC
  7. Cimini A
  8. Castelli V
  9. Bertini R
  10. Montopoli M
  11. Cocetta V
  12. Borocci S
  13. Prandi IG
  14. Flavahan K
  15. Bahr M
  16. Napiorkowski A
  17. Chillemi G
  18. Ooka M
  19. Yang X
  20. Zhang S
  21. Xia M
  22. Zheng W
  23. Bonaventura J
  24. Pomper MG
  25. Hooper JE
  26. Morales M
  27. Rosenberg AZ
  28. Nettles KW
  29. Jain SK
  30. Allegretti M
  31. Michaelides M